Dan Rothman

Dan Rothman currently serves in dual leadership roles as Chief Information Officer for Sumitovant Biopharma and Chief Digital Officer for parent company Sumitomo Dainippon Pharma where he has built an entire digital ecosystem across both organizations. This includes establishing platforms such as data engineering and DevOps, building a digital strategy team, and leading enterprise technology and infrastructure, all designed to unlock new value through novel applications of technology. His team has doubled in size annually since inception and identified more than 50 solutions that improve drug discovery, accelerate clinical trials and improve commercialization. Previously he was the Chief Information Officer for Roivant Sciences.

Dan is an innovative leader with a proven track record of leveraging technology to drive digital and behavioral transformation across businesses. He is highly skilled at building and inspiring teams to achieve organizational growth through technology and has specific expertise in applying technology to traditional sectors including healthcare and finance.

Dan’s approach to applied technology has been formed through his unique career journey. After graduating with bachelor’s and master’s degrees in electrical engineering and computer science from MIT, Dan spent a brief time in Silicon Valley as a computer chip designer before embarking on a 20-year career in finance with firms including Goldman Sachs and Lehman Brothers. During this time, he built trading, sales and analytics businesses and revolutionized them with the application of new technology approaches. Dan carried these learnings to his career in pharmaceuticals, looking for opportunities where technology can disrupt how value is created and how to solve business problems through existing methodologies applied in alternate ways.